KWELLADA-P CRÈME RINSE 1 %
PERMETHRIN : 1 % · DIN 02231480 · MEDTECH PRODUCTS INC
Health Canada status: MARKETED
What is KWELLADA-P CRÈME RINSE?
KWELLADA-P CRÈME RINSE 1 % contains PERMETHRIN : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02231480, held by MEDTECH PRODUCTS INC, supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as marketed, status dated 15-Feb-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is KWELLADA-P CRÈME RINSE used for?
Treatment of Pediculus capitis (head lice), including adults, nymphs and eggs.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is KWELLADA-P CRÈME RINSE called?
The same molecule, PERMETHRIN, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Eralyce | Latin | Saudi Arabia |
| Lyclear | Latin | Australia |
| TIC TAC | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02231480 |
|---|---|
| Brand name | KWELLADA-P CRÈME RINSE |
| Generic / active ingredient | PERMETHRIN : 1 % |
| Manufacturer | MEDTECH PRODUCTS INC |
| Strength | 1 % |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | P03AC04 PERMETHRIN |
| AHFS class | 84:04.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 15-Feb-2013 |
| Original market date | 1998-11-16 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02231480 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231480 |
| Brand name | KWELLADA-P CRÈME RINSE |
| Active ingredient / INN | PERMETHRIN : 1 % |
| ATC code | P03AC04 |
| ATC anatomical main group | P — Antiparasitic products, insecticides and repellents |
| ATC therapeutic subgroup | P03 |
| AHFS class | 84:04.12 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | MEDTECH PRODUCTS INC |
How is it administered?
Apply 25-50 mL to saturated shampooed, towel-dried hair and scalp. Leave on for 10 minutes, then rinse thoroughly. A second treatment may be used after 7 days if needed.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15° and 30°C.
How is it supplied?
Plastic bottles containing 50 mL and 200 mL.
Which pack is which?
| Strength on the label | 1 % |
|---|---|
| Dosage form | LIQUID |
| Route | TOPICAL |
| Packaging as described in the monograph | Plastic bottles containing 50 mL and 200 mL. |
| Storage | Store between 15° and 30°C. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
Known sensitivity to permethrin, any components of the product, other pyrethroids or pyrethrins, or to chrysanthemums.
Warnings and precautions
For external use only. Avoid contact with eyes (may cause irritation). Discontinue if hypersensitivity occurs. Not for prophylactic use. Wear gloves if applying routinely.
What can be used instead?
Other Canadian products sharing ATC code P03AC04 PERMETHRIN. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KWELLADA-P LOTION | 5 % | LOTION | MEDTECH PRODUCTS INC | MARKETED | DIN 02231348 |
| NIX CREME RINSE | 1 % | CREAM | INSIGHT PHARMACEUTICALS, LLC | MARKETED | DIN 00771368 |
| NIX DERMAL CREAM | 5 % | CREAM | HALEON CANADA ULC | MARKETED | DIN 02219905 |
| NIX DERMAL CREAM 5% | 5 % | CREAM | BURROUGHS WELLCOME INC., CONSUMER PROD DIVISION | CANCELLED POST MARKET | DIN 01943154 |
Who else supplies PERMETHRIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PERMETHRIN appears in 21 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PERMETHRIN cost around the world?
PERMETHRIN is listed on 5 national price registers Nexara tracks, across 9 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Saudi Arabia | public | 1 | 3 | 01 Sep 2026 |
| United States | acquisition | 1 | 3 | 03 Sep 2026 |
| Australia | ex-manufacturer | 1 | 1 | 08 Sep 2026 |
| Bahrain | retail (max) | 1 | 1 | 01 Sep 2026 |
| United Kingdom | hospital | 1 | 1 | 31 Aug 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.